Skip to main content

Table 2 Treatment of patients < 80 years with Type 1 myocardial infarction (n = 28,404), Norway 2013–2016

From: Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease

  Prior coronary artery disease No prior coronary artery disease  
n = 7219 n = 21,185
  Missing data   Missing data
n (%) n (%) n (%) n (%) Odds ratio (95% CI, p)1) Age- and gender-adjusted odds ratio (95% CI, p)1)
Coronary angiogram 5951 (82) 2 (0) 18,873 (89) 0 (0) 0.6 (0.5–0.6, < 0.001) 0.6 (0.6–0.7 < 0.001)
Percutaneous coronary intervention (PCI) 4179 (58) 0 (0) 15,178 (72) 1 (0) 0.6 (0.6–0.7, < 0.001) 0.6 (0.6–0.7, < 0.001)
Medication at discharge (discharged alive, n = 27,442)
 Acetylsalicylic acid 6682 (96) 5 (0) 19,907 (97) 20 (0) 0.8 (0.7–0.9, < 0.001) 0.9 (0.7–1.0, 0.03)
 Dual antiplatelet therapy (DAPT) 5949 (86) 12 (0) 18,228 (89) 32 (0) 0.8 (0.7–0.8, < 0.001) 0.9 (0.8–0.9, 0.001)
 Statins 6348 (92) 7 (0) 18,985 (93) 26 (0) 0.9 (0.8–0.9, 0.003) 0.9 (0.8–1.0, 0.06)
  1. 1) Reference: No prior coronary artery disease
\